|1.||Jaeschke, R: 3 articles (01/2004 - 01/2001)|
|2.||Hood, W B: 3 articles (01/2004 - 01/2001)|
|3.||Guyatt, G H: 3 articles (01/2004 - 01/2001)|
|4.||Dans, A: 2 articles (01/2001 - 01/2001)|
|5.||Pastelín Hernández, Gustavo: 1 article (09/2015)|
|6.||de Micheli Serra, Alfredo: 1 article (09/2015)|
|7.||Jelliffe, Roger W: 1 article (05/2014)|
|8.||Hood, William B: 1 article (01/2014)|
|9.||Jaeschke, Roman: 1 article (01/2014)|
|10.||McMurray, John J V: 1 article (01/2014)|
03/01/1991 - "Despite 200 years of use, the ability of digitalis glycosides to improve exercise capacity in patients with congestive heart failure remains controversial, partly because of imprecise end points and suboptimal study design. "
10/01/1989 - "The future place of digitalis glycosides in the treatment of cardiac failure will depend on the results of studies comparing them with new positive inotropic drugs. "
09/01/2015 - "Since the end of the XVIII century, digitalis glycosides were employed in heart failure. "
01/01/2014 - "Digitalis glycosides have been in clinical use for the treatment of heart failure (HF) for longer than 200 years. "
05/01/2013 - "Digitalis glycosides are known to improve the hemodynamic and neurohormonal perturbations that contribute to heart failure (HF)-induced renal dysfunction (RD). "
05/01/2014 - "This report examined the role of digitalis pharmacokinetics in helping to guide therapy with digitalis glycosides with regard to converting atrial fibrillation (AF) or flutter to regular sinus rhythm (RSR). "
01/01/1994 - "[The use of digitalis glycosides in atrial fibrillation]."
09/01/1991 - "Digitalis glycosides have been shown in humans to improve various parameters of CHF in a subset of patients with either atrial fibrillation or third heart sounds. "
10/01/1989 - "Digitalis glycosides have an antiarrhythmic effect in atrial fibrillation, as defibrillatory drugs. "
01/01/2001 - "However, the important role of digitalis glycosides as therapeutic comedication or alternative was never denied, especially in atrial fibrillation with tachycardia. "
05/26/1976 - "Effects of hypoxia and digitalis glycosides on myocardial stiffness."
09/01/1991 - "The purpose of this study was to determine whether digitalis glycosides alter the effect of anoxia and reoxygenation on the cardiac myocytes and whether it could be modified by inhibition with amiloride. "
09/01/1991 - "These findings indicate the potentially deleterious effects of digitalis glycosides in myocardial anoxia and reoxygenation and the ability of amiloride to oppose these adverse effects."
09/01/1991 - "Digitalis glycosides accentuate the depressant effect of anoxia and reoxygenation on the cardiac myocyte: antagonism by amiloride."
12/01/2010 - "To study the clinical efficacy and safety of the Esculin and Digitalis glycosides Eye Drops used in the patients of ametropic asthenopia. "
12/01/2010 - "[The clinical efficacy and safety study of Esculin and Digitalis glycosides Eye Drops in treating ametropic asthenopia]."
12/01/2010 - "The experiment was conducted asthenopia patients who used the Esculin and Digitalis glycosides Eye Drops for 4 weeks continuously. "
12/01/2010 - "Esculin and Digitalis glycosides Eye Drops is effective and safety for use in the patients of ametropia asthenopia."
|5.||Cardiac Arrhythmias (Arrythmia)
01/01/1980 - "[Digitalis glycosides and arrhythmia]."
04/20/1979 - "Available evidence suggests that the propensity of digitalis glycosides to produce cardiac arrhythmias is due in part to their neuroexictatory effects. "
01/20/1977 - "[Myocardial excitability under the influence of digitalis glycosides and anti-arrhythmia agent]."
01/01/1977 - "5 It was concluded that sampling the large areas of neural tissue above could provide no evidence for local accumulation of digitalis glycosides that might account for a central nervous system origin of digitalis-induced cardiac arrhythmias."
01/01/2005 - "The extracellular domain of this enzyme contains a highly conserved receptor for a plant-derived family of compounds, the digitalis glycosides, used in the treatment of congestive heart failure, and certain cardiac arrhythmias. "
|3.||Ophthalmic Solutions (Eye Drops)
|8.||Vasodilator Agents (Vasodilators)
|9.||Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)
|10.||Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)